Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ConmedFRA:EC8 81 EV-to-OCF is 15.49 as of Aug. 21, 2026, which is 57% below its 10-year median of 35.94. GuruFocus rates FRA:EC8 with a GF Score™ of 81/100 and a GF Value™ of €57.51 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Conmed ranks worse than 66.86% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Conmed's Enterprise Value is €2,001 Mil.
Conmed's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €129 Mil. Therefore, Conmed's EV-to-OCF for today is 15.49.
The historical rank and industry rank for Conmed's EV-to-OCF or its related term are showing as below:
FRA:EC8'
s EV-to-OCF Range Over the Past 10 Years
Min: 10.97 Med: 35.94 Max: 180.58
Current: 15.51
During the past 13 years, the highest EV-to-OCF of Conmed was 180.58. The lowest was 10.97. And the median was 35.94.
FRA:EC8's EV-to-OCF is ranked worse than 66.86% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.54
vs FRA:EC8: 15.51
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-21), Conmed's stock price is €43.80.
Conmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €1.595. Therefore, Conmed's PE Ratio (TTM) for today is 27.46.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Conmed's share price for today is €43.80.
Conmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.595.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Conmed EV-to-OCF Related Terms
Conmed EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Conmed's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Conmed's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conmed EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conmed's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Conmed's EV-to-OCF falls into.
Conmed's current Enterprise Value is €2,001 Mil.
Conmed's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €129 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conmed (FRA:EC8) has a EV-to-OCF of 15.49 as of Aug. 21, 2026. This is 57% below median its historical median of 35.94. Over the past decade, Conmed's EV-to-OCF has ranged from 10.97 to 180.58. According to the industry distribution chart, Conmed ranks #569 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 66.9%.
Is Conmed's EV-to-OCF too high?
Conmed's current EV-to-OCF of 15.49 is 57% below median its 10-year median of 35.94. Over the past 10 years, this metric has ranged from a low of 10.97 to a high of 180.58. The Medical Devices & Instruments industry median EV-to-OCF is 7.54. Conmed's value of 15.49 is 105.4% above this industry median. Based on the distribution chart, Conmed ranks #569 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Conmed has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's EV-to-OCF compare to ATEC and AORT?
According to the Medical Devices & Instruments industry distribution chart, Conmed ranks #569 out of 851 companies for EV-to-OCF. This places Conmed in the lower half of its industry. The industry median EV-to-OCF is 7.54. Conmed's value of 15.49 is 105.4% above this benchmark. Historically, Conmed's own EV-to-OCF has ranged from 10.97 to 180.58 over the past decade. While the company's 10-year median is 35.94 vs. the industry median of 7.54, Conmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.54, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Conmed's current EV-to-OCF of 15.49 is 105.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conmed's current EV-to-OCF is 15.49, which is 57% below median its own 10-year median of 35.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (FRA:EC8) is currently considered Modestly Undervalued. The stock's GF Value™ is €57.51, compared to a current price of €43.80 — trading 23.8% below its estimated fair value. The current EV-to-OCF is 15.49, which is 57% below median its 10-year median of 35.94 and 105.4% above the Medical Devices & Instruments industry median of 7.54. Conmed's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Conmed (FRA:EC8), the current EV-to-OCF is 15.49 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conmed (FRA:EC8) Overvalued in 2026?
Based on GuruFocus' analysis, Conmed stock appears to be undervalued.
The current stock price of €43.80 is trading 23.8% below its estimated GF Value™ of €57.51.
GuruFocus considers Conmed to be Modestly Undervalued.
Key valuation signals for FRA:EC8:
EV-to-OCF: 15.49 (57% below median its 10-year median of 35.94)
GF Value™: €57.51 vs. price of €43.80 (23.8% below fair value)
Industry Position: 105.4% above the Medical Devices & Instruments median (#569 of 851)
No single metric tells the full story. See the FRA:EC8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
81GF Score
Get the complete analysis for FRA:EC8
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EC8 has been successfully added to your 
